Insmed
(NASDAQ) INSM
Insmed Financials at a Glance
Market Cap
$23.60B
Revenue (TTM)
$819.56M
Net Income (TTM)
-$1.18B
EPS (TTM)
-$5.74
P/E Ratio
-18.96
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Price
$109.00
Volume
48
Open
$107.82
Price
$109.00
Volume
48
Open
$107.82
Previous Close
$108.87
Daily Range
$105.00 - $109.74
52-Week Range
$65.56 - $212.75
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Price
$109.00
Volume
48
Open
$107.82
Previous Close
$108.87
Daily Range
$105.00 - $109.74
52-Week Range
$65.56 - $212.75
INSM News
INSM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Insmed
Industry
Biotechnology
Sector
Health CareEmployees
1,664
CEO
Will Lewis, MBA
Website
www.insmed.comHeadquarters
Bridgewater, NJ 08807, US
INSM Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
-294%
Return on Capital
-66%
Return on Assets
-57%
Earnings Yield
-5.27%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$23.60B
Shares Outstanding
216.75M
Volume
48
Avg. Volume
2.84M
Financials (TTM)
Gross Profit
$481.55M
Operating Income
-$1.18B
EBITDA
-$1.17B
Operating Cash Flow
-$935.01M
Capital Expenditure
-$32.56M
Free Cash Flow
-$967.58M
Cash & ST Invst.
$1.43B
Total Debt
$768.16M
Insmed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$305.96M
+229.6%
Gross Profit
$256.46M
+258.5%
Gross Margin
83.82%
N/A
Market Cap
$23.60B
N/A
Market Cap/Employee
$18.57M
N/A
Employees
1,271
N/A
Net Income
-$163.56M
+36.3%
EBITDA
-$194.59M
+16.4%
Quarterly Fundamentals
Net Cash
$475.08M
+531.3%
Accounts Receivable
$178.56M
+274.0%
Inventory
$132.91M
+32.0%
Long Term Debt
$734.01M
-43.5%
Short Term Debt
$14.43M
+40.5%
Return on Assets
-57.02%
N/A
Return on Invested Capital
-65.83%
N/A
Free Cash Flow
-$226.22M
+16.9%
Operating Cash Flow
-$222.74M
+15.0%